GATRALIMAB
UNII 87MNT78TAZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Gatralimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 87MNT78TAZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1826020-80-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
87MNT78TAZ
CAS Registry Number
1826020-80-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GATRALIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C175072
National Cancer Institute reference terminology for clinical and research data.
INN ID
11046
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gatralimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GATRALIMAB

Common Names & Synonyms

GATRALIMAB [INN]
IMMUNOGLOBULIN G1, ANTI-(CD ANTIGEN CD52) (HUMAN-MUS MUSCULUS MONOCLONAL GZ402668 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GZ402668 LIGHT CHAIN, DIMER

Technical Codes

GZ402668
GZ-402668

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus